Antiviral therapy prolongs survival in immune tolerant hepatitis B patients
A new study, presented today at The International Liver Congress 2016 in Barcelona Spain, demonstrates that the use of antiviral therapy for patients in the immune tolerant phase of Hepatitis B (HBV) prolongs overall survival ...
Apr 15, 2016
0
14